189,190 Research using blood samples from subjects given the blood thinner medications aspirin, clopidogrel, or ticagrelor (Brilinta) suggests EGCG may improve their antiplatelet effects without increasing the risk of bleeding
This computational prediction relies on analyzing reliable experimental data of NPs structure, physicochemical properties and biological activity, as well as the measured toxicity (Richarz et al., 2017)
You may experience pain, itching, swelling or redness around the injection site, nausea, vomiting, diarrhoea, and headache
Schedule a free call
A 250 mcg target amount equals 0.1 mL, or 10 insulin units